1911 Gold Announces C$20 Million “Best Efforts” Life Offering and Private Placement
/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / 1911 Gold Corporation (‘
Osisko Intersects 330.6 Metres Averaging 0.46% Cu in Southern Extension at Gaspé
Osisko Metals Incorporated (the ‘ Company or ‘ Osisko Metals ‘) ( TSX: OM,OTC:OMZNF ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is
FORTUNE BAY ACCELERATES DEVELOPMENT AT GOLDFIELDS FOLLOWING STRONG PEA AND FINANCING
Development-ready gold asset in premier mining jurisdiction with funded advancement plan; preparing to initiate project-development and exploration drill program Fortune Bay Corp. (TSXV:
ReeXploration Identifies Large-Scale Uranium Target at Eureka Project, Namibia
Discovery of uranium mineralization in ideal geological setting, supported by regional radiometric anomaly, confirms large Rossing-style target ReeXploration Inc. (TSXV: REE) (FSE: K2I0)
Terra Clean Closes the Acquisition of the Past Producing Uranium Claims in San Rafael Swell, Utah, United States
Terra Clean Energy CORP. (‘ Terra ‘ or the ‘ Company ‘) (CSE: TCEC,OTC:TCEFF, OTCQB: TCEFF FSE: C 9O0) is pleased to
CHARBONE Confirms Construction Schedule on Track at Sorel-Tracy and Announces the Imminent Start of Equipment Installation Phase
(TheNewswire) Brossard, Quebec TheNewswire
CHARBONE confirme le respect de l’echeancier de construction a Sorel-Tracy et annonce le debut imminent de la phase d’installation des equipements
(TheNewswire) Brossard, Quebec TheNewswire
Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.
Questcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (the ‘Company’ or ‘Questcorp’) is pleased to announce that Sorbie Bornholm LP (‘Sorbie’),
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division —









